12895_2018_74_MOESM1_ESM.docx (23.22 kB)
Additional file 1: of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
journal contribution
posted on 2018-07-11, 05:00 authored by Rosarin Sruamsiri, Kosuke Iwasaki, Wentao Tang, Jรถrg MahlichAppendix A. ICD codes for disease to be excluded. Appendix B. Dosage regimen of included BTs. Appendix C. Gap definition (days) of included BTs in base case and sensitivity analysis (SA) 1 and 2. Appendix D. The rates of (number of persistent patients during the 12-month period after BT initiation/number of total patients) calculated in the base case and sensitivity analysis (SA) 1 and 2. (DOCX 23 kb)